These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19336395)

  • 1. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2009 May; 284(20):13570-13576. PubMed ID: 19336395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding.
    Adak S; Yang KS; Macdonald-Obermann J; Pike LJ
    J Biol Chem; 2011 Dec; 286(52):45146-55. PubMed ID: 22069315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
    Thiel KW; Carpenter G
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19238-43. PubMed ID: 18042729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.
    Odaka M; Kohda D; Lax I; Schlessinger J; Inagaki F
    J Biochem; 1997 Jul; 122(1):116-21. PubMed ID: 9276679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for negative cooperativity in growth factor binding to an EGF receptor.
    Alvarado D; Klein DE; Lemmon MA
    Cell; 2010 Aug; 142(4):568-79. PubMed ID: 20723758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational coupling across the plasma membrane in activation of the EGF receptor.
    Endres NF; Das R; Smith AW; Arkhipov A; Kovacs E; Huang Y; Pelton JG; Shan Y; Shaw DE; Wemmer DE; Groves JT; Kuriyan J
    Cell; 2013 Jan; 152(3):543-56. PubMed ID: 23374349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth.
    Song WX; Vacca MF; Welti R; Rintoul DA
    J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.
    Adak S; DeAndrade D; Pike LJ
    J Biol Chem; 2011 Jan; 286(2):1545-55. PubMed ID: 21047778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding.
    Saxon ML; Lee DC
    J Biol Chem; 1999 Oct; 274(40):28356-62. PubMed ID: 10497195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the catalytic activity of the EGF receptor.
    Endres NF; Engel K; Das R; Kovacs E; Kuriyan J
    Curr Opin Struct Biol; 2011 Dec; 21(6):777-84. PubMed ID: 21868214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.
    Macdonald-Obermann JL; Pike LJ
    Biochemistry; 2009 Mar; 48(11):2505-13. PubMed ID: 19196031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
    Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
    Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent.
    Gill K; Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2017 Dec; 292(50):20744-20755. PubMed ID: 29074618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The juxtamembrane region of the EGF receptor functions as an activation domain.
    Red Brewer M; Choi SH; Alvarado D; Moravcevic K; Pozzi A; Lemmon MA; Carpenter G
    Mol Cell; 2009 Jun; 34(6):641-51. PubMed ID: 19560417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
    Sanders JM; Wampole ME; Thakur ML; Wickstrom E
    PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence.
    He L; Hristova K
    Sci Rep; 2012; 2():854. PubMed ID: 23152945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
    Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
    J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time measurements of kinetics of EGF binding to soluble EGF receptor monomers and dimers support the dimerization model for receptor activation.
    Zhou M; Felder S; Rubinstein M; Hurwitz DR; Ullrich A; Lax I; Schlessinger J
    Biochemistry; 1993 Aug; 32(32):8193-8. PubMed ID: 8347619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.
    Macdonald JL; Pike LJ
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):112-7. PubMed ID: 18165319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.